Features September 2019 Issue

JAK Inhibitors for Rheumatoid Arthritis

JAK Inhibitors for Rheumatoid Arthritis

A new class of medications for rheumatoid arthritis has a unique effect on the immune system.

Drugs for rheumatoid arthritis work by blocking parts of the immune system from wreaking havoc. Most people with rheumatoid arthritis start with the disease-modifying antirheumatic drug (DMARD) methotrexate, usually taken as a pill (but is also available as an injection). It has a proven track record as an effective medication. There are other DMARDs as well. Methotrexate doesn't work well enough for everyone, and some people have side effects.

To continue reading this article you must be a paid subscriber.

Subscribe to Arthritis Advisor

Arthritis Advisor is the first magazine published by one one of the world's leading orthopaedic hospitals specifically for people with arthritis.

Subscriber Log In

Forgot your password? Click Here.

Already subscribe but haven't registered for all the benefits of the website? Click here.